Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up
Author(s) -
Takayoshi Nishioka,
Shoji Kubo,
Shogo Tanaka,
Kenichi Wakasa,
Shigekazu Takemura,
Masahiko Kinoshita,
Genya Hamano,
Yuko Kuwae,
Toshihiko Shibata,
Shigefumi Suehiro
Publication year - 2016
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000367752
Subject(s) - medicine , gastroenterology , dyslipidemia , group b , intrahepatic cholangiocarcinoma , group a , diabetes mellitus , metastasis , portal hypertension , lymph node , fatty liver , cirrhosis , endocrinology , cancer , disease
The outcomes of hepatic resection in intrahepatic cholangiocarcinoma (ICC) patients with diabetes mellitus (DM), hypertension (HT), and dyslipidemia (DL) (metabolic components) remain unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom